XML 63 R83.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Segment Information (Revenue by Reportable Segment) (Details) (USD $) In Millions, unless otherwise specified | 3 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2012
Segment Reporting Information |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue | $ 22,894 | [1] | $ 21,427 | $ 22,240 | $ 24,523 | $ 25,420 | $ 24,552 | $ 25,232 | $ 25,889 | $ 91,084 |  | $ 101,093 |  | $ 107,552 |
Pharmaceutical |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue |  |  |  |  |  |  |  |  |  | 80,110 | [2] | 91,097 | [2] | 97,925 | [2]
Medical |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue |  |  |  |  |  |  |  |  |  | 10,962 |  | 10,060 |  | 9,642 |
Reportable Segments |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue |  |  |  |  |  |  |  |  |  | 91,072 |  | 101,157 |  | 107,567 |
Corporate |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue |  |  |  |  |  |  |  |  |  | $ 12 | [3] | $ (64) | [3] | $ (15) | [3]
Walgreens Co | Pharmaceutical |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contract expiration date |  |  |  |  |  |  |  |  |  | Aug. 31, 2013 |  |  |  |  |
Express Scripts, Inc. | Pharmaceutical |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contract expiration date |  |  |  |  |  |  |  |  |  |  |  | Sep. 30, 2012 |  |  |
[1] | During the fourth quarter of fiscal 2014, we recorded an out-of-period decrease in revenue of $14 million related to customer pricing adjustments, of which $1 million pertained to each of the first three quarters of fiscal 2014 and each quarter of fiscal 2013. The amounts were not material individually or in the aggregate to current or prior periods.
[2] | Our pharmaceutical distribution contract with Walgreens expired on August 31, 2013. Our pharmaceutical distribution contract with Express Scripts, Inc. expired on September 30, 2012.
[3] | Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.

X
- Definition Contract expiration date + References No definition available. + Details
Name: | cah_ContractExpirationDate
Namespace Prefix: | cah_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration